Mumbai, November 10, 2025: Remedium Lifecare Ltd., a fast-emerging player in the pharmaceutical supply chain and specialty chemicals sector, has announced the appointment of Mr. Vignesh Laxman Gawde as Whole-Time Director and Mr. Rambhajan Vishwakarma as Independent Director.
Strengthening leadership for expansion
According to Mr. Adarsh Munjal, Managing Director of Remedium Lifecare, these appointments come at a pivotal time as the company accelerates its growth momentum. “Mr. Gawde’s deep technical expertise in the pharmaceutical field and Mr. Vishwakarma’s vast experience in the financial sector will bring a strong strategic balance to our leadership team,” he said.
About the new appointees
Mr. Vignesh Laxman Gawde brings over 14 years of experience in pharmaceutical research and analytical development, having worked with leading firms such as Ajanta Pharma, Inventia Healthcare, and Elder Pharmaceuticals. Holding an M.Sc. in Physical Chemistry from the Institute of Science, Mumbai University, he will focus on strengthening R&D, quality assurance, and innovation across key therapeutic areas including anti-infectives, cardiovascular, and CNS treatments.
Mr. Rambhajan Vishwakarma has over 15 years of experience in the banking and financial services industry, having worked with HDFC Bank, ICICI Bank, HDB Financial Services, Capri Global, and Andromeda Sales & Distribution. His expertise in retail finance, business development, and strategic sales will aid the company’s financial prudence and governance oversight.
Strategic direction ahead
The appointments mark a key step in building a future-ready leadership team, combining pharmaceutical innovation with financial acumen. Remedium Lifecare aims to enhance its R&D capabilities, operational efficiency, and market presence in both domestic and global markets.
About the company
Remedium Lifecare Ltd., founded in 1988, is a BSE-listed pharmaceutical and specialty chemicals company engaged in the trading and distribution of raw materials for the pharmaceutical industry. The company focuses on quality, compliance, and global reach, with growing emphasis on R&D and CDMO services.
Disclaimer: The information provided above is based on the company’s official press release and is intended for informational purposes only.
